Granules India LtdPharmaceuticalsINE101D01020Consolidated₹875.50+5.10 (+0.59%)Jun-26
Valuation
Market Cap₹21.69K Cr
TTM PE32.35x
Forward PE30.29x
PEG3.02
Book Value₹205.21
P/B4.27x
TTM EPS₹27.06
Fwd EPS₹28.91
TTM Revenue₹5.63K Cr
TTM PAT₹662.35 Cr
TTM EBITDA₹1.28K Cr
TTM EBIT₹970.38 Cr
Last Qtr PAT₹179.96 Cr
Last Qtr EBITDA₹338.90 Cr
Last Qtr EBIT₹259.25 Cr
Profitability
ROE13.03%
ROCE15.05%
TTM NPM11.76%
TTM EBITDA %22.68%
Curr OPM12.17%
Last OPM13.63%
Curr NPM—
Last NPM—
Curr EPS₹7.26
Last EPS₹8.23
Balance sheet
Equity₹24.78 Cr
Reserve₹5.06K Cr
Total Debt₹1,512.04 Cr
D/E0.30x
Interest %11.74%
Curr Interest₹21.12 Cr
Price / range
Close₹875.50
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+0.59%
1W+0.34%
1M+2.85%
3M+11.94%
6M+49.08%
1Y+61.17%
2Y+59.88%
3Y+168.06%
5Y+167.04%
Diwali+41.37%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits